{"name": "SARcode Bioscience",
 "permalink": "sarcode-corporation",
 "crunchbase_url": "http://www.crunchbase.com/company/sarcode-corporation",
 "homepage_url": "http://www.sarcode.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "SARcode@sarcode.com",
 "phone_number": "",
 "description": "",
 "created_at": "Wed Apr 21 09:22:19 UTC 2010",
 "updated_at": "Tue Jul 19 01:31:25 UTC 2011",
 "overview": "\u003Cp\u003ESARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; \u00ce\u00b1L\u00ce\u00b22) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other inflammatory diseases. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       104],
      "assets/images/resized/0008/4418/84418v5-max-150x150.jpg"],
     [[250,
       174],
      "assets/images/resized/0008/4418/84418v5-max-250x250.jpg"],
     [[450,
       313],
      "assets/images/resized/0008/4418/84418v5-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Quinton",
      "last_name": "Oswald",
      "permalink": "quinton-oswald",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$73M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.sarcode.com/about.html",
    "source_description": "SARcode secured $25 million in financing ",
    "raised_amount": 29000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 12,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2011/07/sarcode-bioscience-closes-44m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "SARcode Bioscience Closes $44M Series B Financing",
    "raised_amount": 44000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 7,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 160000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130325e93ppxssv\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130325e93ppxssv%26from%3dalert%26pid%3d32",
   "source_description": "Shire to Acquire Dry-Eye Drug Developer SARcode Bioscience ",
   "acquired_year": 2013,
   "acquired_month": 3,
   "acquired_day": 25,
   "acquiring_company":
    {"name": "Shire",
     "permalink": "shire",
     "image":
      {"available_sizes":
        [[[150,
           44],
          "assets/images/resized/0009/6378/96378v1-max-150x150.png"],
         [[150,
           44],
          "assets/images/resized/0009/6378/96378v1-max-250x250.png"],
         [[150,
           44],
          "assets/images/resized/0009/6378/96378v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1000 Marina Blvd.",
    "address2": "Suite 250",
    "zip_code": "94005",
    "city": "Brisbane",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        117],
       "assets/images/resized/0008/4419/84419v1-max-150x150.jpg"],
      [[250,
        196],
       "assets/images/resized/0008/4419/84419v1-max-250x250.jpg"],
      [[450,
        353],
       "assets/images/resized/0008/4419/84419v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}